Are you Dr. Pisters?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Unit 1373
Houston, TX 77030Phone+1 713-792-3250
Summary
- Dr. Louis Pisters, MD is a board certified urologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Arizona. He is affiliated with University of Texas M.D. Anderson Cancer Center and is a Professor at Division of Surgery.
Education & Training
- University of Texas Health Science Center at HoustonResidency, Urology, 1991 - 1993
- University of FloridaResidency, Urology, 1988 - 1991
- University of FloridaResidency, Surgery, 1986 - 1988
- University of Western OntarioClass of 1986
Certifications & Licensure
- FL State Medical License 2024 - Present
- AZ State Medical License 2024 - 2027
- TN State Medical License 2024 - 2026
- AL State Medical License 2024 - 2025
- GA State Medical License 2024 - 2025
- LA State Medical License 2024 - 2025
- MS State Medical License 2024 - 2025
- American Board of Urology Urology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases.Georges C Tabet, Lan Zheng, Hossein Hosseini, John Ward, Louis Pisters
Human Pathology. 2024-11-01 - Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life.Sagar A Patel, Dattatraya Patil, Joseph Smith, Christopher S Saigal, Mark S Litwin
JAMA Network Open. 2024-10-01 - 1 citationsA phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates.Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin, Miao Zhang, Yao Yu
BJU International. 2024-09-01
Press Mentions
- Salvage Cryotherapy for Recurrent PCa May Provide Long-Term Oncologic ControlMay 4th, 2021
- Pathology Report Gives Prostate Cancer Survivor More Treatment OptionsDecember 10th, 2018
Professional Memberships
- Member